ライフサイエンスコーパス: communicable

1 Vitamin D deficiency is associated with non-communicable and infectious diseases, but the vitamin D

2 Arab countries are now dealing with both non-communicable and infectious diseases.

3 could increase global deaths yearly from non-communicable and malnutrition-related diseases by 1.42 m

4 ophone Africa still carries a high burden of communicable and neonatal diseases, probably due to the

5 seen in all age-groups and regions, although communicable and non-communicable diseases remained the

6 Worldwide, communicable and non-communicable diseases tend to segre

7 h this increasingly prevalent dual burden of communicable and non-communicable diseases.

8 and varies with inflammation rooted in both communicable and non-communicable diseases.

9 health burden with risk factors that include communicable and non-communicable diseases.

10 We assessed the burden of select communicable and noncommunicable diseases (NCDs) in SIV

11 The dynamics, control, and evolution of communicable and vector-borne diseases are intimately co

12 istinctness metrics are effective yet easily communicable and versatile tools to assist objective glo

13 timated disease burdens of non-communicable, communicable, and malnutrition-related diseases with the

14 per 100,000 population by age and gender, by communicable (CD) and non-communicable disease (NCD) cau

15 Major challenges to human health are non-communicable chronic diseases, often driven by altered i

16 e examined the behavioural correlates of non-communicable, chronic disease risk in low-income countri

17 o turn the tide of the growing burden of non-communicable, chronic, adult diseases that have their or

18 We estimated disease burdens of non-communicable, communicable, and malnutrition-related dis

19 With non-communicable conditions accounting for nearly two-thirds

20 odevelopmental impairment, stunting, and non-communicable conditions.

21 Most countries have endorsed WHO non-communicable disease (NCD) best buy policies, but we kno

22 The non-communicable disease (NCD) burden in Kenya is not well c

23 disease contributes substantially to the non-communicable disease (NCD) burden in low-income and midd

24 age and gender, by communicable (CD) and non-communicable disease (NCD) causes.

25 ession was used to analyse all-cause and non-communicable disease (NCD) mortality between 2006 and 20

26 The reduction by a third of premature non-communicable disease (NCD) mortality by 2030 is the ambi

27 et 3.4, current policy and monitoring of non-communicable disease (NCD) mortality trends focus on peo

28 mong 10,040 Kurdish adults from Ravansar Non-Communicable Disease (RaNCD) cohort study in Iran.

29 C, especially as countries pivot towards non-communicable disease and injury care.

30 reduce mortality at age 5-69 years from non-communicable disease and injury comprising the highest s

31 The communicable disease and non-communicable disease sector

32 Since this transition, the prevention of non-communicable disease as well as communicable disease cau

33 ciation between socioeconomic status and non-communicable disease behavioural risk factors is well es

34 cated in substantial global increases in non-communicable disease burden in low-income, remote, and I

35 otal disease burden in 2016, whereas the non-communicable disease burden increased.

36 an ageing global population comes major non-communicable disease burden, especially in low-income an

37 Given the changing nature of communicable disease burden, subnational vaccination may

38 D-19 pandemic has shown how a newly emergent communicable disease can lay considerable burden on publ

39 ntion of non-communicable disease as well as communicable disease causes of adolescent mortality has

40 He was hired by the US Communicable Disease Center (now the Centers for Disease

41 When the Communicable Disease Center (now the Centers for Disease

42 I outline the Communicable Disease Center's first surveillance systems

43 Hypertension is a non-communicable disease characterized by elevated blood pre

44 rganization was notified of an outbreak of a communicable disease characterized by fever, severe diar

45 e notification database at the Department of Communicable Disease Control and Prevention in Stockholm

46 al Administrative Region, Harvard Center for Communicable Disease Dynamics from the National Institut

47 ramme and Wellcome Trust, Harvard Center for Communicable Disease Dynamics, and Health and Medical Re

48 e burden of morbidity and mortality from non-communicable disease has risen worldwide and is accelera

49 lth service use of an additional chronic non-communicable disease in different socioeconomic groups a

50 ned from a community-based management of non-communicable disease in Nepal (COBIN) Wave II study, whi

51 ommendations: WHO's package of essential non-communicable disease interventions (PEN) and South Afric

52 lions of patients suffering from chronic non-communicable disease like diabetes.

53 tis programme that offers a portfolio of non-communicable disease medicines at a wholesale price of U

54 ustainable Development Goals 3.4 (reduce non-communicable disease morbidity by a third by 2030) and 3

55 opment Goal (SDG) 3.4-reducing premature non-communicable disease mortality by a third by 2030-should

56 Sequencing pathogen samples during a communicable disease outbreak is becoming an increasingl

57 o other strategies to address increasing non-communicable disease rates must be pursued.

58 rs, due to population ageing, changes in non-communicable disease rates, and increasing air pollution

59 of diets associated with lower or higher non-communicable disease risk on the basis of multivariate m

60 The communicable disease and non-communicable disease sectors need to move beyond convent

61 ciated with the damaging inflammation of non-communicable disease states and is considered an attract

62 An additional chronic non-communicable disease was associated with an increase in

63 al artery disease is a prevalent chronic non-communicable disease without obvious symptoms.

64 ies (around 50% of DALYs attributable to non-communicable disease), whereas China more closely resemb

65 ies (around 80% of DALYs attributable to non-communicable disease).

66 is study shows the reversal of HIV/AIDS, non-communicable disease, and injury mortality trends in Sou

67 side from HIV/AIDS, few CL episodes involved communicable disease, and none occurred in least-develop

68 y later overweight increases the risk of non-communicable disease, by imposing a high metabolic load

69 Tuberculosis is a major communicable disease.

70 Obesity is a common cause of non-communicable disease.

71 hich has a growing prevalence of chronic non-communicable disease.

72 entation of an effective response to the non-communicable-disease crisis will need political commitme

73 The threat of non-communicable diseases ("NCDs") is increasingly becoming

74 (-9.64%, 95% CI -6.38 to -12.90), other non-communicable diseases (-9.14%, -4.26 to -14.02), and tub

75 den of Disease Study 2010, the burden of non-communicable diseases (cardiovascular disease, cancer, c

76 of overweight, obesity, and diet-related non-communicable diseases (DR-NCDs) have been proposed as a

77 individuals towards risk of Diet Related Non-communicable Diseases (DR-NCDs).

78 uintile for HIV/AIDS and tuberculosis, other communicable diseases (excluding HIV/AIDS and tuberculos

79 hy eating guidelines that aim to prevent non-communicable diseases (increase fruits, vegetables, whol

80 e varied substantially by health topic, from communicable diseases (n=131), nutrition (n=77), to non-

81 e diseases (n=131), nutrition (n=77), to non-communicable diseases (n=8), and water, sanitation, and

82 Heightened risk of non-communicable diseases (NCD) in children exposed to SAM a

83 income countries, care for patients with non-communicable diseases (NCDs) and mental health condition

84 Non-communicable diseases (NCDs) are leading causes of prema

85 e premature mortality from the four main non-communicable diseases (NCDs) by 25% from 2010 levels by

86 Non-communicable diseases (NCDs) cause a large burden of dis

87 approaches to prevention and control of non-communicable diseases (NCDs) have been elaborated in the

88 The burden of non-communicable diseases (NCDs) is disproportionately carri

89 World Health Organization 2014 report on non-communicable diseases (NCDs) only listed smoking, alcoho

90 Non-communicable diseases (NCDs) such as cardiovascular dise

91 unities have a higher risk of dying from non-communicable diseases (NCDs) than do more advantaged gro

92 tes to the development of many prevalent non-communicable diseases (NCDs), and these lifestyle-associ

93 ps remain in quality of care, control of non-communicable diseases (NCDs), efficiency in delivery, co

94 xperiencing an increase in the burden of non-communicable diseases (NCDs), including cancer.

95 As with most non-communicable diseases (NCDs), oral conditions are chroni

96 of 30 years and 70 years) from four main non-communicable diseases (NCDs)--cardiovascular diseases, c

97 le will increasingly develop age-related non-communicable diseases (NCDs).

98 vide an untapped opportunity to identify non-communicable diseases (NCDs).

99 tion leading to increasing prevalence of non-communicable diseases (NCDs).

100 isk factors shared with a range of other non-communicable diseases (NCDs).

101 deaths; a third of premature deaths from non-communicable diseases (NCDs); and a third of those from

102 n Plan for the Prevention and Control of Non-communicable Diseases 2013-2020, and in advancing the UN

103 millions of adults at increased risk of non-communicable diseases after low birthweight.

104 the UN's political commitment to address non-communicable diseases and ensure universal access to dru

105 inued to shift away from communicable to non-communicable diseases and from premature death to years

106 nized as a major risk factor for chronic non-communicable diseases and has been estimated to contribu

107 l persist in LICs--whereas the burden of non-communicable diseases and injuries has increased.

108 n learnt about prevention and control of non-communicable diseases and injuries, which is well summar

109 ow confronting an increasing burden from non-communicable diseases and injuries.

110 ion with age-standardised mortality from non-communicable diseases and injuries.

111 ceed the incremental gains in decreasing non-communicable diseases and injury burdens of high-income

112 ommunicable diseases narrowed over time, non-communicable diseases and injury burdens varied markedly

113 nificant global health burdens from both non-communicable diseases and micronutrient deficiencies.

114 ns, while at the same time, diet-related non-communicable diseases and obesity have exponentially inc

115 Urgent action is now required to control non-communicable diseases and reduce fatal injuries in Mexic

116 onal differences in the unfinished agenda of communicable diseases and reproductive, maternal, and ch

117 e solution is city planning that reduces non-communicable diseases and road trauma while also managin

118 of infections allows treatment of potential communicable diseases and updating of immunizations.

119 dult mortality risks from infections and non-communicable diseases are a result of historical childho

120 Non-communicable diseases are increasingly common causes of

121 poor, which population interventions for non-communicable diseases are most applicable in different c

122 Chronic, non-communicable diseases are now recognised as diseases tha

123 Non-communicable diseases are the leading global cause of de

124 rd reduction in premature mortality from non-communicable diseases by 2030.

125 itiative, a plan to cut mortality due to non-communicable diseases by 25% by 2025.

126 tobacco use and premature mortality from non-communicable diseases by a third by 2030.

127 re developed for key nutrients linked to non communicable diseases by an independent scientific commi

128 ct of physical inactivity on these major non-communicable diseases by estimating how much disease cou

129 ch about half the mortality reduction in non-communicable diseases called for by the Sustainable Deve

130 ing factual information about the dangers of communicable diseases can positively impact people's att

131 onitoring of patients with other symptomatic communicable diseases caused by E. coli at global scale.

132 Data were collected for communicable diseases commonly screened for during the e

133 The burden of communicable diseases decreased but continues to predomi

134 isorders including diabetes, cardiovascular, communicable diseases etc.

135 rominently in the burgeoning epidemic of non-communicable diseases facing low- and middle-income coun

136 illness (ILI) to the National Institute for Communicable Diseases for influenza testing by immunoflu

137 logical evidence, the policy response to non-communicable diseases has been weak.

138 High rates of non-communicable diseases have also been described with evid

139 wever, socioeconomic factors influencing non-communicable diseases have not been included in the plan

140 ted to the Norwegian Surveillance System for Communicable Diseases in 2005-2014 and 249998 individual

141 e diseases in children towards those for non-communicable diseases in adults.

142 society by preventing and treating not only communicable diseases in all ages, but also noncommunica

143 Asthma-one of the most common chronic, non-communicable diseases in children and adults-is characte

144 stantially, with a shift away from risks for communicable diseases in children towards those for non-

145 han 3 million deaths per year, most from non-communicable diseases in low-income and middle-income co

146 health guidance on prevention and control of communicable diseases in prison settings.

147 unicable diseases, and the shift towards non-communicable diseases in recent decades.

148 , care, and treatment, and management of non-communicable diseases in the poorest populations.

149 2008, with 446 annual excess deaths from non-communicable diseases in the UK (280 for young people ag

150 Mortality from non-communicable diseases in the UK fell from being roughly

151 ne of the most common, life-threatening, non-communicable diseases in the world and a major public he

152 ight the need to focus more attention on non-communicable diseases in this population and balance obe

153 nges of contact tracing for high-consequence communicable diseases included rapid comprehensive conta

154 Deaths from non-communicable diseases increased over time in both sexes,

155 As the prevalence of injuries and non-communicable diseases increases, the provision of effect

156 and diagnostic yield of integrating NCD and communicable diseases into a rapid HIV testing and refer

157 ty of integrating hypertension, diabetes and communicable diseases into HIV initiatives.

158 ntries in the Gulf region, the burden of non-communicable diseases is a major threat, primarily due t

159 The epidemiological transition towards non-communicable diseases is characterised by an upward shif

160 and increasing burden of mortality from non-communicable diseases is likely to become prominent.

161 by mass drug administration programs against communicable diseases may necessitate increased vector c

162 Although state inequalities from communicable diseases narrowed over time, non-communicab

163 Cancer is one of the major non-communicable diseases posing a threat to world health.

164 rategy of seeking natural factors in the non-communicable diseases prevention, but their sensory qual

165 Growing political recognition of non-communicable diseases provides a favourable political co

166 The rise in diabetes and other non-communicable diseases puts a heavy toll on health system

167 s and regions, although communicable and non-communicable diseases remained the main causes of death

168 Deaths from non-communicable diseases rose by just under 8 million betwe

169 t in the global monitoring framework for non-communicable diseases should promote accountability for

170 Treatment of non-communicable diseases such as cancer in refugees is negl

171 verse health conditions, including major non-communicable diseases such as coronary heart disease, ty

172 f many pathologies, particularly chronic non-communicable diseases such as obesity and diabetes.

173 s, one can find regions having predominantly communicable diseases such as rheumatic heart disease, t

174 and prescribed medicines for one of the non-communicable diseases targeted by the programme: hyperte

175 Worldwide, communicable and non-communicable diseases tend to segregate geographically.

176 We assess risks of communicable diseases that are associated with mass gath

177 coronary heart disease and other chronic non-communicable diseases that lower global life expectancie

178 nfancy and childhood as well as chronic, non-communicable diseases that may manifest at any point acr

179 e to worldwide epidemics of injuries and non-communicable diseases through traffic exposure, noise, a

180 te the risk of cardiometabolic and other non-communicable diseases through various mechanisms.

181 We used 11 physical non-communicable diseases to measure physical multimorbidity

182 DC from an agency focused almost entirely on communicable diseases to one engaged in a broad array of

183 Moreover, high costs for non-communicable diseases warrant new features for preventio

184 Substantial declines in death caused by communicable diseases were seen in all age-groups and re

185 n treatment, blood glucose level, having non-communicable diseases were significantly associated with

186 culosis remains one of the world's deadliest communicable diseases with 10 million incident cases and

187 herapies include commonly used drugs for non-communicable diseases with good safety profiles, immunom

188 s and accounts for the largest burden of non-communicable diseases worldwide.

189 and nutritional diseases; injuries; and non-communicable diseases); health risks (tobacco smoking, b

190 tal, and nutritional disorders, 43% from non-communicable diseases, and 10% from injuries.

191 alth security, antimicrobial resistance, non-communicable diseases, and climate change-but also the t

192 (MDGs), addressing growing challenges of non-communicable diseases, and ensuring universal health cov

193 Mortality from tuberculosis, non-communicable diseases, and injuries decreased slightly.

194 rnal, perinatal, and nutritional causes, non-communicable diseases, and injury.

195 ogenic agents is likely to prevent other non-communicable diseases, and the cause could be removed or

196 ale natural disasters, epidemics of multiple communicable diseases, and the shift towards non-communi

197 earance or severity of multiple chronic, non-communicable diseases, as these diseases share the same

198 ment (PPE) can limit transmission of serious communicable diseases, but this process poses challenges

199 vative assumptions for each of the major non-communicable diseases, by country, to estimate how much

200 fting burden from infectious diseases to non-communicable diseases, cancer care for all ages has beco

201 Among chronic non-communicable diseases, cardiometabolic diseases and canc

202 However, amid Mexico's progress against communicable diseases, chronic kidney disease burden rap

203 injuries, cancers, cirrhosis, and other non-communicable diseases, democratic experience explains mo

204 child health, other infectious diseases, non-communicable diseases, Ebola, and sector-wide approaches

205 Development Goals and the challenges of non-communicable diseases, economic inequality, and climate

206 modify the major risk factors related to non-communicable diseases, especially physical inactivity an

207 s early life factors in the aetiology of non-communicable diseases, including asthma/wheezing disorde

208 Non-communicable diseases, including cancer, are overtaking

209 regions, and has an increasing burden of non-communicable diseases, including cardiovascular diseases

210 flict includes death and disability from non-communicable diseases, including diabetes, which have la

211 l epidemiological trends and the rise of non-communicable diseases, including diabetes.

212 The most common non-communicable diseases, including ischaemic heart disease

213 rly for infant deaths and mortality from non-communicable diseases, including neuropsychiatric disord

214 t bacteria, mass casualty incidents, and non-communicable diseases, including thermal disorders.

215 ICs, with interventions focused primarily on communicable diseases, including tuberculosis and malari

216 everal risks that primarily affect childhood communicable diseases, including unimproved water and sa

217 f two or more mental or physical chronic non-communicable diseases, is a major challenge for the heal

218 ated at the international level, such as non-communicable diseases, mental health, and injuries.

219 action: malaria 8.0% and syphilis 7.7%), non-communicable diseases, nutrition and lifestyle factors (

220 he HIV epidemic, and increasing rates of non-communicable diseases, people in sub-Saharan Africa are

221 focus areas (other infectious diseases, non-communicable diseases, sector-wide approaches, and other

222 Unlike most communicable diseases, the absolute burden and relative

223 transitions from diseases of poverty to non-communicable diseases, the burden of disease and health

224 a reduction in global child mortality due to communicable diseases, the relative contribution of cong

225 The burden of non-communicable diseases, to which cancer contributes great

226 nd a third of those from other causes (other communicable diseases, undernutrition, and injuries).

227 Most increases in DALYs, especially from non-communicable diseases, were due to population growth.

228 r Ingelheim; Department of Management of Non-Communicable Diseases, WHO; and Population Health Resear

229 ity on addressing the high prevalence of non-communicable diseases, with variations in policies betwe

230 DALYs from non-communicable diseases--especially ischaemic heart diseas

231 h preventing and controlling the rise of non-communicable diseases.

232 k of hormone-sensitive cancers and other non-communicable diseases.

233 revalent dual burden of communicable and non-communicable diseases.

234 as obesity, diabetes, and other chronic non-communicable diseases.

235 with no discernible funding targeted to non-communicable diseases.

236 the effective prevention and containment of communicable diseases.

237 n metabolic syndrome, diabetes and other non-communicable diseases.

238 rt of a comprehensive strategy to reduce non-communicable diseases.

239 ammation rooted in both communicable and non-communicable diseases.

240 ould be a risk of development of chronic non communicable diseases.

241 e no detailed assessments of late-onset, non-communicable diseases.

242 ological transition from communicable to non-communicable diseases.

243 annually through its effects on multiple non-communicable diseases.

244 patterns are a global priority to reduce non-communicable diseases.

245 beginning to confront the rising tide of non-communicable diseases.

246 rtality, growth failure, and adult-onset non-communicable diseases.

247 in the context of the growing burden of non-communicable diseases.

248 s with expertise in control of infection and communicable diseases.

249 d help prevent such diet-related chronic non-communicable diseases.

250 sk factors that include communicable and non-communicable diseases.

251 val and reduce disability, stunting, and non-communicable diseases.

252 tributor to adult obesity, diabetes, and non-communicable diseases.

253 and to address the emerging burden from non-communicable diseases.

254 neonatal, and nutritional causes towards non-communicable diseases.

255 added visceral fat and increased risk of non-communicable diseases.

256 ove treatment effectiveness, and address non-communicable diseases.

257 fing PPE for simulated patients with serious communicable diseases.

258 ive development, and increase risks from non-communicable diseases.

259 ng populations and the growing burden of non-communicable diseases.

260 it potential biological activity against non-communicable diseases.

261 National Institute for Communicable Diseases: Division of the National Health L

262 atal, and nutritional disorders; second, non-communicable diseases; and third, injuries.

263 iven to the issue of access to medicines for communicable diseases; however, access to essential medi

264 equirements for reducing the burden from non-communicable disorders (including stroke), brought toget

265 icable, nutritional, or maternal causes; non-communicable disorders; and injury.

266 CTs had significantly higher rates of acute communicable findings in all categories, except for acut

267 Acute communicable findings in at least one of four categories

268 The frequency of any acute communicable findings in neuroscience, medical, and surg

269 ion of altered mental status yields abnormal communicable findings.

270 REVIEW: Babesiosis is a zoonosis, a disease communicable from animals to humans and an important blo

271 hereas the three leading causes were all non-communicable in states with very low mortality.

272 en by altered immunity and inflammation, and communicable infections from agents which harbour antibi

273 vely common but does not routinely result in communicable infections in the new host.

274 environment, and uncontrolled cancer-causing communicable infections.

275 ions means that many people with chronic non-communicable lung diseases are not given effective treat

276 Unlike many other non-communicable lung diseases, the proximal causes of many

277 isability-adjusted life-years [DALYs] due to communicable, maternal, and nutritional diseases; injuri

278 Communicable, maternal, neonatal, and nutritional causes

279 th rates combine to drive a broad shift from communicable, maternal, neonatal, and nutritional causes

280 At the most aggregate level, communicable, maternal, neonatal, and nutritional causes

281 Nevertheless, communicable, maternal, neonatal, and nutritional causes

282 -24 380.7]) was almost equivalent to that of communicable, maternal, neonatal, and nutritional diseas

283 distinguishes three broad categories: first, communicable, maternal, neonatal, and nutritional disord

284 In 1990, 47% of DALYs worldwide were from communicable, maternal, neonatal, and nutritional disord

285 In sub-Saharan Africa, however, many communicable, maternal, neonatal, and nutritional disord

286 re than a third of national DALYs arose from communicable, maternal, perinatal, and nutritional disor

287 We aimed to assess non-communicable multimorbidity (co-occurrence of two or mor

288 HIV was not a risk factor for increased non-communicable multimorbidity.

289 90, premature death and disability caused by communicable, newborn, nutritional, and maternal disorde

290 by Global Burden of Disease classification: communicable, nutritional, or maternal causes; non-commu

291 5-49 years; 15% at ages 50-69 years; 30% for communicable, perinatal, maternal, or nutritional causes

292 Non-communicable respiratory diseases are an increasing prob

293 , but are large enough to carry a variety of communicable respiratory pathogens.

294 atible with typical transmission dynamics of communicable respiratory viruses that might exploit CDHR

295 Non-communicable risk factors were the leading cause of DALY

296 Nod2 deficiency gives rise to a reversible, communicable risk of colitis and colitis-associated carc

297 s and infectious diseases with long-term non-communicable sequelae, and did narrative reviews between

298 language and develop explicit, symbolic, and communicable systems of knowledge that deliver rich repr

299 ease burden has continued to shift away from communicable to non-communicable diseases and from prema

300 xamining the epidemiological transition from communicable to non-communicable diseases.

301 Genotype-dependent disease risk was communicable via maternally transmitted microbiota in bo

302 Importance: Measles is a highly communicable viral infection with serious complications.